The marijuana stock market has managed to be one of the more confusing markets to participate in if one doesn’t know the ins and outs of how an infant industry works. In the last several months, we’ve seen a vast increase in the amount of interested investors within the space. This has helped to bring in some needed capital to the cannabis market, but in turn has ended up making the industry more speculative than ever. Although this can be a good thing at times, speculative trading has managed to make the marijuana stock market have large fluctuations which has turned some investors off in recent times. With the passing of Canadian legislation to make recreational cannabis legal, it seems as though we are entering a new era where marijuana stocks can be invested in safely without the threat of these massive price swings.
Scythian Biosciences Corp. (SCCYF/SCYB) is “a pre-clinical research and development company that is in the process of developing drug therapies.” The company is based out of Canada which puts them at the perfect exposure to one of the largest legal cannabis markets in the world. In recent times, the company made headlines after investing $88 million in “Class B units in Verano Holdings, LLC (“Verano”), a private, Delaware organized, vertically integrated, licensed operator of cannabis cultivation, manufacturing and retail facilities across six key U.S. states and Puerto Rico.” The hopes are that this will help to expand their horizon into not only how they can produce various products, but how they can begin to create various distribution channels into the future. The company has also stated that they have agreed to sell 100% interest in 3 Boys Farms LLC, which will help the two build more capital as they move toward the future of the industry.
Aphria (NASDAQOTH:APHQF) has been one of the main growers of cannabis for the whole of the cannabis market. When they are at full capacity, they are subject to be able to grow as much as 255,000 kilograms of cannabis per year. The company also have two extremely large facilities which are aimed at producing the highest quality, and highest yields possible. The company has also stated that they have the ability to generate as much as 437% in fiscal growth throughout next year. This is in combination with the 180% they are scheduled to grow by the end of the 2020 fiscal year. All in all, Aphria remains one of the pure-play cannabis companies with the highest amount of value for the coming year and beyond.
Cannabis as a whole has remained a tricky space to invest in for some time now. As the market continues to mature over the course of the next few years, hopefully the issues with stability will be able to pan out. This will likely help to bring in a whole new slew of investors willing to take part in one of the most exciting industries of the modern day. Until then, it seems to be a waiting game as to when the market can see its true value reflected in the prices of the most popular businesses.
Pursuant to an agreement between an affiliate of MAPH Enterprises, LLC (owners of MarijuanaStocks.com), Midam Ventures LLC and Scythian Biosciences, Midam is being paid $90,000 for a period of 3 months beginning August 29, 2018, and ending November 29, 2018. We own 0 shares of Scythian Biosciences. We may buy or sell additional shares of (SCCYF/SCYB) in the open market at any time, including before, during or after the Website and Information, to provide public dissemination of favorable Information about Scythian Biosciences.
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers